Fecal transplant for advanced stomach cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have advanced stomach or esophagus cancer that has spread or cannot be removed by surgery
- You are willing to provide a tumor sample and have at least one tumor that can be measured on a scan (not in the brain)
- You are generally active and able to care for yourself (ECOG 0 or 1)
- You are not currently taking antibiotics or strong immune-suppressing drugs (like high-dose steroids)
- You do not have HIV, active hepatitis B/C, inflammatory bowel disease, or a history of severe allergic reactions to certain foods or anesthesia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of fecal microbiota transplant (FMT), chemotherapy (SOX), and an immunotherapy drug (Sintilimab) as a first treatment for advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery. The goal is to see if this combination can shrink tumors and improve outcomes.
This study tests whether fecal microbiota transplantation (FMT) – transferring healthy gut bacteria via capsules – can help prevent or ease digestive side effects (like diarrhea or constipation) caused by cancer treatment for extrapulmonary neuroendocrine neoplasms. If you are experiencing such symptoms, this approach might improve your quality of life during treatment.
This study tests a combination of fecal microbiota transplant, chemotherapy, radiation, and immunotherapy (sintilimab) for people with locally advanced rectal cancer. The goal is to see if this approach improves treatment outcomes.
This trial tests whether adding a fecal microbiota transplant (FMT) to standard first-line chemotherapy can help shrink or control advanced colorectal cancer that cannot be surgically removed. FMT is a procedure that introduces healthy donor bacteria into your gut to possibly boost your body's response to treatment.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
This study tests if giving patients a stool transplant (also called FMT) in capsules along with their first chemotherapy can help treat advanced pancreatic cancer that cannot be removed by surgery.
Hear when a new Advanced Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.